Abstract
Anticancer treatment has become a research highlight in recent years. Despite several techniques have been developed and applied in the clinic, this area still meets great challenges in the construction of smart anticancer devices with accurate targeting, controlled release and microenvironment response properties. Most of the carbon-based materials are biocompatible, possessing abundant and tunable pore structures and particularly large surface areas. These properties make them suitable materials as drug carriers. In addition, some carbon-based materials are capable of absorbing near-infrared radiation (NIR) and have highly efficient photothermal effects. The generated heat in situ can be used to kill cancer cells in short time on the position. This review describes the recent and significant application of four kinds of carbon materials including carbon nanotubes, graphene, carbon dots and mesoporous carbon for drug delivery and photothermal therapy. After a short introduction of the structures and properties of these materials, the construction and application of these nanoplatforms in drug delivery, photothermal therapy or their combination will be summarized and discussed in depth. In addition, other carbon allotropes as drug carriers will be introduced briefly. Finally, the risk assessments and the perspectives and challenges of these materials used in cancer therapies are enclosed.
Keywords: Carbon-based nanomaterial, drug delivery, photothermal therapy, near-infrared, biomaterial, carbon allotropes.
Current Pharmaceutical Design
Title:Advanced Carbon-based Nanoplatforms Combining Drug Delivery and Thermal Therapy for Cancer Treatment
Volume: 24 Issue: 34
Author(s): Yanhong Xu, Yuling Shan, Hailin Cong, Youqing Shen and Bing Yu*
Affiliation:
- Institute of Biomedical Materials and Engineering, College of Chemistry and Chemical Engineering, College of Materials Science and Engineering, Qingdao University, Qingdao 266071,China
Keywords: Carbon-based nanomaterial, drug delivery, photothermal therapy, near-infrared, biomaterial, carbon allotropes.
Abstract: Anticancer treatment has become a research highlight in recent years. Despite several techniques have been developed and applied in the clinic, this area still meets great challenges in the construction of smart anticancer devices with accurate targeting, controlled release and microenvironment response properties. Most of the carbon-based materials are biocompatible, possessing abundant and tunable pore structures and particularly large surface areas. These properties make them suitable materials as drug carriers. In addition, some carbon-based materials are capable of absorbing near-infrared radiation (NIR) and have highly efficient photothermal effects. The generated heat in situ can be used to kill cancer cells in short time on the position. This review describes the recent and significant application of four kinds of carbon materials including carbon nanotubes, graphene, carbon dots and mesoporous carbon for drug delivery and photothermal therapy. After a short introduction of the structures and properties of these materials, the construction and application of these nanoplatforms in drug delivery, photothermal therapy or their combination will be summarized and discussed in depth. In addition, other carbon allotropes as drug carriers will be introduced briefly. Finally, the risk assessments and the perspectives and challenges of these materials used in cancer therapies are enclosed.
Export Options
About this article
Cite this article as:
Xu Yanhong , Shan Yuling , Cong Hailin, Shen Youqing and Yu Bing *, Advanced Carbon-based Nanoplatforms Combining Drug Delivery and Thermal Therapy for Cancer Treatment, Current Pharmaceutical Design 2018; 24 (34) . https://dx.doi.org/10.2174/1381612825666181120160959
DOI https://dx.doi.org/10.2174/1381612825666181120160959 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
GSK3 Inhibitors in the Therapeutic Development of Diabetes, Cancer and Neurodegeneration: Past, Present and Future
Current Pharmaceutical Design Anti-CTLA4 Monoclonal Antibody Ipilimumab in the Treatment of Metastatic Melanoma: Recent Findings
Recent Patents on Anti-Cancer Drug Discovery Editorial [Hot Topic: Prospective Clinical Role for Anticancer Garlic Organosulfur Compounds (Guest Editor: Hassan T. Hassan)]
Anti-Cancer Agents in Medicinal Chemistry Evaluation Method of Mechanical Properties of Living NSCLC Cells Based on Nano-indentation
Current Nanoscience Toxicogenomics
Current Drug Metabolism Editorial (Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health - A Close Up on Africa and Womens Health)
Current Pharmacogenomics and Personalized Medicine Design of NAALADase Inhibitors A Novel Neuroprotective Strategy
Current Medicinal Chemistry Pharmacokinetics of Biotech Drugs: Peptides, Proteins and Monoclonal Antibodies
Current Drug Metabolism Large-Scale and Facile Synthesis of Biocompatible Yb-Based Nanoparticles as a Contrast Agent for In Vivo X-Ray Computed Tomography Imaging
Current Topics in Medicinal Chemistry MDM4 (MDMX) and its Transcript Variants
Current Genomics Breast Cancer Stem Cells and Sex Steroid Hormones
Current Stem Cell Research & Therapy The Scatter Factor Signaling Pathways as Therapeutic Associated Target in Cancer Treatment
Current Medicinal Chemistry Synthesis and Anti-thyroid Cancer Effect of Iodo-chrysin Derivatives
Medicinal Chemistry Double Point Modified Analogs of Vitamin D as Potent Activators of Vitamin D Receptor
Current Pharmaceutical Design Self-micro Emulsifying Drug Delivery System “SMEDDS” for Efficient Oral Delivery of Andrographolide
Drug Delivery Letters Docking and Virtual Screening to Identify PKC Agonists: Potentials in Anticancer Therapeutics
Current Computer-Aided Drug Design Biosimilars Regulation in the United States and FDA Approved Biosimilars from 2015-2018
Applied Clinical Research, Clinical Trials and Regulatory Affairs Breast Cancer Diagnosis Using Data Mining Methods, Cumulative Histogram Features, and Gary Level Co-occurrence Matrix
Current Medical Imaging Mass Spectrometric Strategies and Their Applications for Molecular Mass Determination of Recombinant Therapeutic Proteins
Current Pharmaceutical Biotechnology DNA Damage and Epigenetic Changes in Kidney Diseases - Focused on Transcription Factors in Podocytes
Current Hypertension Reviews